Make provision about methods of testing the safety of medicines; and for connected purposes.
The Bill proposes the establishment of a Medicines Safety Evaluation Panel to compare the effectiveness of human biology-based tests and animal-based tests in assessing the safety of medicines. The panel would be required to report within two years and would have full access to all relevant records held by the Medicines and Healthcare Products Regulatory Agency.
House of Commons
1 May 2012
May contain errors — check source documents for definitive information.
The Safety of Medicines Bill would set up a Medicines Safety Evaluation Panel to compare safety tests based on human biology with traditional animal tests. The panel would report its findings within two years and would have full access to all relevant records held by the MHRA to help decide which tests best assess medicine safety.
The bill is at the 2nd reading in the House of Commons; further stages (such as committee consideration and Lords scrutiny) have not yet begun.
Generated 21 February 2026
20 Jul 2010
No recorded votes for this bill yet.
